Arkolith/Insider Trading/PTCT/Form 4

Klein Matthew B.

CHIEF EXECUTIVE OFFICER, DirectorPTC THERAPEUTICS, INC. (PTCT) · full profile →Form 4 · filed May 15, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$917K
Net Open-Market Flow
-$917K
Transactions
5
5 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 14, 2026Sell(S)679$73.06$50K406K
May 14, 2026Sell(S)7K$73.08$528K399K
May 14, 2026Sell(S)2K$73.08$153K397K
May 14, 2026Sell(S)3K$72.46$186K394K
May 13, 2026Grant(A)13K—$0407K

Transaction Codes

S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001808968-26-000015) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML